pharma · Advanced Solid Tumor · Acute Myeloid Leukemia or Myelodysplastic Syndromes · APRE
Aprea Therapeutics
Aprea Therapeutics clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
3805 Old Easton Rd, Doylestown, Pennsylvania 18902, US HQ
15 Employees
Public company Type
APRE · NYSE Ticker
Company details
- Status
- Public
- HQ
- 3805 Old Easton Rd, Doylestown, Pennsylvania 18902, US
- Employees
- 15
- Programs
- 15
- Drugs
- 5
- Patents
- 6
Aprea Therapeutics projects
1 ClinicalTrials.gov programs sponsored by Aprea Therapeutics.
Aprea Therapeutics has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Aprea Therapeutics have?
1 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.